Pfizer is preparing to start clinical trials of its COVID-19 candidate in the US next week, and says it could have it ready for emergency use as early as the autumn if the FDA signs off the study quickly.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,